Deployable Anywhere
High Capacity
Fully Stand Alone
COVID-19 |
Influenza A/B |
||
---|---|---|---|
Rapid Antigen | (15 minute) | Rapid Influenza A/B | (15 minute) |
Rapid PCR | (30 minute) | ||
Lab PCR | (24 hour) | ||
DRUG TESTING |
TUBERCULOSIS |
||
Saliva | Multi-Panel/ | QuantiFERON | (72 hours) |
Urine | Custom Specific | Mantoux (TST) | (48-72 hours) |
VACCINATIONS |
IV DRIPS |
||
COVID-19 & Boosters | B12 | ||
Influenza | Vitamin D | ||
Vitamin C | |||
Folic Acid |
ALL-IN-ONE HEALTH MANAGEMENT SOLUTION FOR EVENTS
FIRST AID STATIONS
Units: 4
Personnel: 62
Minimum: 16800
Maximum: 33600
Units: 16
Personnel: 50
Minimum: 13440
Maximum: 26880
Units: 2
Personnel: 25
Minimum: 6720
Maximum: 13440
Units: 1
Personnel: 7
Minimum: 1680
Maximum: 3360
Units: 20
Personnel: 10
Minimum: 2520
Maximum: 5040
Units: 2
Personnel: 7
Minimum: 1680
Maximum: 3360
The antigen home test is authorized for nonprescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 2 and older. This test is also authorized for nonprescription home use with self-collected (unobserved) direct anterior nasal (NS) swab specimens from individuals aged 14 years and older or with adult-collected anterior NS samples from individuals aged 2 years or older. The test to be used in individuals within 6-days of symptom onset or individuals without symptoms or other epidemiological reasons to suspect COVID-19 infection when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests.
Deployable Anywhere
High Capacity
Fully Stand Alone
API/SDK Integration
Federal, State Reporting
HIPAA Compliant – Fully Encrypted
Secure App Testing
Rapid Result Delivery
Test History
Chief Executive Officer
Chief Medical Officer
Chief Development Officer
Chief Clinical Officer
Chief Technology Officer
Vice President, Sales
Director of Clinical Operations
Director of Operations
Head Scientist
For one of our retail drive thru locations, see below: